Neurology® Podcast

Latest Episodes:

September 13 2011 Issue Sep 12, 2011

Show notes

1) Natalizumab-associated PML and 2) Topic of the month: Preventive neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alex Bragg interviews Dr. Avindra Nath about his paper on natalizumab-associated PML. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Eagle syndrome. In the next part of the podcast Dr. Matt Barrett interviews Dr. Paula Rackoff on patients' steroids and prevention of osteoporosis. Over the subsequent two weeks, Ted Burns will interview GianPietro Sechi and David Saperstein on B vitamin deficiencies. The participants had nothing to disclose except Drs. Nath and Clardy.Dr. Nath serves on scientific advisory boards for Biogen Idec and DioGenix, Inc.; serves as an Associate Editor for the Journal of Neurovirology; may accrue revenue on patents re: Tat as an immunogen, Diosgenin for Treatment of Neurodegenerative Diseases, Role of Kv Channels in Neuroregeneration and Protection, Role of Lominoid compounds as neuroprotective agents, and Tat ELISA; has served as a consultant for Nerveda Inc. and Elan Corporation; receives research support from the NIH; and has served as an expert advice in medico-legal cases.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section.

September 6 2011 Issue Sep 07, 2011

Show notes

1) 60th anniversary editorial and 2) Topic of the month: Preventive neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Robert Griggs about his editorial describing his tenure as Editor for the journal. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Lafora disease. In the next part of the podcast Dr. Matt Barrett interviews Dr. Renee Shellhaas about vitamin D deficiency in children with epilepsy. Next week Matt Barrett will interview Paula Rackoff about steroids and vitamin D, Calcium and osteoporosis. The participants had nothing to disclose except Drs. Burns, Griggs, Clardy, and Shellhaas.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Griggs serves as Chair of Executive Committee of the Muscle Study Group, which receives support from pharmaceutical companies; has served on scientific advisory boards for The National Hospital Queen Square and PTC Therapeutics, Inc.; serves on the editorial boards of NeuroTherapeutics and Current Treatment Opinions in Neurology; receives royalties from the publication of Andreoli and Carpenter's Cecil Essentials of Medicine, Eighth Edition (W.B. Saunders Company, 2000, 2004, 2007, and 2010) and Cecil Textbook of Medicine, 24th Edition (Saunders, 2000, 2004, 2008, and 2010, in press); and has received research support from TaroPharma and the NIH/NINDS, the FDA, and the Muscular Dystrophy Association.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Shellhaas receives research support from the NIH, University of Michigan through the Janette Ferrantino Investigator Award 2010 and Charles Woodson Pediatric Biostatics Fund Major Award 2011, and Child Neurology Foundation, Shields Fellowship Award 2009-2011.

Delayed Recall - September 2011 Sep 01, 2011

Show notes

Interview with Oliver Sacks about his book, The Mind's Eye

August 30 2011 Issue Aug 29, 2011

Show notes

1) Duty hour neurology residencies and 2) Topic of the month: Stroke and stroke care. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Bazant interviews Dr. Lori Schuh about her paper on IOM duty hour recommendations in neurology residencies. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about supranuclear gaze palsy: Think beyond PSP. In the next part of the podcast Dr. Brett Kissela interviews Dr. Tom Brott about CREST to finish our monthly theme on stroke care. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Schuh, Fugate, and Kissela.Dr. Schuh is a member of the ACGME Neurology Review Committee.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela has served on the scientific advisory board for for Allergan, Inc.; receives honoraria from Allergan, Inc; receives research support from the NIH; and gave expert testimony in medico legal cases related to stroke.

August 23 2011 Issue Aug 22, 2011

Show notes

1) Spinal cord lymphoma and 2) Topic of the month: Stroke and stroke care. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jennie Taylor interviews Drs. Mark Keegan and Eoin Flanagan about their paper on spinal cord lymphoma. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about palatal myoclonus. In the next part of the podcast Dr. Brett Kissela interviews Dr. Mark Eckman about new anticoagulants. Next week, Dr. Kissela will interview Dr. Tom Brott about CREST. The participants had nothing to disclose except Drs. Keegan, Fugate, Kissela and Eckman.Dr. Keegan serves as Clinical Pathological Conference Section Co-Editor for Neurology® and neurology podcast Panel and Chief Editor for eMedicine; and has served as a consultant for Novartis.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela has served on the scientific advisory board for for Allergan, Inc.; receives honoraria from Allergan, Inc; receives research support from the NIH; and gave expert testimony in medico legal cases related to stroke. Dr. Eckman has served as an editorial board member of the American College of Physicians PIER chapter, is a consultant for Savient Pharmaceuticals, Inc., receives research support from the NIH, Merck Serono, Gilead Sciences, Inc., and The Foundation for Informed Medical Decision Making.

August 16 2011 Issue Aug 15, 2011

Show notes

1) Fragile X premutation and 2) Topic of the month: Stroke and stroke care. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brandy Matthews interviews Dr. Kim Cornish about her paper on markers of at-risk profiles associated with the fragile X premutation. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about the "cookie test" for brachial plexus birth injury. In the next part of the podcast Dr. Brett Kissela interviews Dr. Bo Norrving about World Stroke Organization and state of stroke care around the world. Over the subsequent two weeks, Dr. Kissela will interview Drs. Mark Eckman and Tom Brott about other aspects of stroke and stroke care. The participants had nothing to disclose except Drs. Matthews, Fugate, and Kissela.Dr. Brandy Matthews receives research support from the NIH.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela has served on the scientific advisory board for for Allergan, Inc.; receives honoraria from Allergan, Inc; receives research support from the NIH; and gave expert testimony in medico legal cases related to stroke.

August 9 2011 Issue Aug 08, 2011

Show notes

1) Functional psychogenic symptoms and 2) Topic of the month: Stroke and stroke care. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Michael Sharpe about his paper on guided self-help for functional (psychogenic) symptoms. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Melkersson-Rosenthal syndrome. In the next part of the podcast Dr. Brett Kissela interviews Drs. Ralph Sacco and Larry Goldstein about prevention of stroke part 2. Over the subsequent three weeks, Dr. Kissela will interview Drs. Bo Norrving, Mark Eckman and Tom Brott about other aspects of stroke and stroke care. The participants had nothing to disclose except Drs. Sharpe, Burns, Fugate, Kissela, Sacco and Goldstein.Dr. Sharpe serves as an Associate Editor for the Journal of Psychosomatic Research and on the editorial boards of General Hospital Psychiatry, Psychological Medicine, and Psychosomatics; serves as an independent medical advisor to AEGON Insurance; receives publishing royalties from Oxford University Press, Wiley-Blackwell and Churchill Livingstone and serves on a DSM5 work group for the American Psychiatric Association; is a member of Council of the Academy of Psychosomatic Medicine and receives research support from the Medical Research Council UK and Cancer Research UK.Dr. Burns receives a stipend as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela has served on the scientific advisory board for for Allergan, Inc.; receives honoraria from Allergan, Inc; receives research support from the NIH; and gave expert testimony in medico legal cases related to stroke. Dr. Sacco serves on a data safety monitoring board indirectly sponsored by Pfizer Inc; serves on the editorial boards of Stroke and Neuroepidemiology; and receives research support from the NIH and the Evelyn McKnight Brain Institute. Dr. Goldstein is a consultant for Allergan, Inc. and Merck Serono; serves on the Steering Committee, SPARCL trial, is a consultant and speaker at meetings in which the SPARCL trial is discussed, Pfizer Inc serves on the Neurology Executive Committee, RESPECT Trial (AGA Medical) Clinical Oversight Committee, and ACT-1 trial (Abbott); and received research support from the RESPECT Trial Site (AGA Medical).

August 2 2011 Issue Aug 01, 2011

Show notes

1) Duchenne muscular dystrophy and 2) Topic of the month: Stroke and stroke care. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Diana Escolar about her paper on weekend versus daily prednisone in Duchenne muscular dystrophy. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Guillain-Barre-like syndrome with thallium poisoning. In the next part of the podcast Dr. Brett Kissela interviews Drs. Ralph Sacco and Larry Goldstein about prevention of stroke part 1. Next week you will hear part 2 and over the subsequent three weeks, Dr. Kissela will interview Drs. Bo Norrving, about other aspects of stroke and stroke care. The participants had nothing to disclose except Drs. Escolar, Fugate, Kissela, Sacco and Goldstein.Dr. Escolar serves on a scientific advisory board for the NIH/NINDS; serves on the speakers' bureau for and has received funding for travel and speaker honoraria from Athena Diagnostics, Inc.; has received speaker honoraria from Kennedy Krieger Institute and Acceleron Pharma; serves as a consultant for Gerson Lheman Group (GLC), Acceleron Pharma, and Medacorp; and receives research support from the NIH, the Muscular Dystrophy Association, and the Foundation to Erradicate Duchenne (FED).Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela has served on the scientific advisory board for for Allergan, Inc.; receives honoraria from Allergan, Inc; receives research support from the NIH; and gave expert testimony in medico legal cases related to stroke. Dr. Sacco serves on a data safety monitoring board indirectly sponsored by Pfizer Inc; serves on the editorial boards of Stroke and Neuroepidemiology; and receives research support from the NIH and the Evelyn McKnight Brain Institute. Dr. Goldstein is a consultant for Allergan, Inc. and Merck Serono; serves on the Steering Committee, SPARCL trial, is a consultant and speaker at meetings in which the SPARCL trial is discussed, Pfizer Inc serves on the Neurology Executive Committee, RESPECT Trial (AGA Medical) Clinical Oversight Committee, and ACT-1 trial (Abbott); and received research support from the RESPECT Trial Site (AGA Medical).

2010-2011 Academic Year Review Jul 29, 2011

Show notes

In this special podcast for the Neurology Journal, Dr. Ted M. Burns plays a dozen of the many interesting audio clips from Neurology Podcasts of the 2010-2011 academic year.

July 26 2011 Issue Jul 26, 2011

Show notes

1) Cost-effectiveness of disease-modifying therapy and 2) Topic of the month: Mononeuropathies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan with Dr. Katia Noyes about her paper on disease-modifying therapy for multiple sclerosis. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about numb chin syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. John Stewart about peroneal neuropathy. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Keegan, Noyes, Fugate and Burns.Dr. Noyes serves on the scientific review panel for the National Multiple Sclerosis Society (NMSS) and has received research support from Biogen Idec, Boston Scientific, the NIH, and the NMSS.Dr. Keegan serves as a Section Editor for Neurology® and as Chief Editor for eMedicine; and has served as a consultant for Novartis and the FDA.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns receives a stipend as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected